The head-and-neck image generated by the RefleXion X1. Credit: Business Wire/ RefleXion.

RefleXion Medical has signed a licensing agreement with Limbus AI to incorporate the latter’s contouring software into its radiotherapy treatment planning system.

The integration of Limbus AI’s Limbus Contour software into RefleXion X1 radiotherapy treatment planning system is aimed at expediting the process of cancer treatment planning.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The manual contouring of tumours and organs at risk (OARs) in radiotherapy planning is a time-intensive task with variability in clinician output. Limbus AI’s Limbus Contour software utilises deep-learning segmentation algorithms to automate this process.

This also helps in reducing human error and ensure more precise radiation delivery.

RefleXion co-founder and chief technology officer Sam Mazin said: “Contouring is one of the most time-consuming tasks in radiotherapy planning, and often contributes to treatment delays.

“We have found Limbus Contour’s AI-driven solution to be a technology leader in speed, accuracy and versatility. Depending on the complexity of the treatment plan, we expect contouring time reductions of up to 80%, thus ensuring that patients receive timely treatment.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Featuring SCINTIX technology, the RefleXion X1 dual-treatment modality radiotherapy platform is capable of treating patients with various stages of solid tumours.

The integration of Limbus Contour is expected to benefit both biologic and anatomic treatment modalities.

Limbus AI CEO Karl Otto said: “The performance of Limbus Contour software relies on the quality of the CT image. X1 images demonstrate high resolution, exceptional contrast, and minimal noise and motion artifacts.

“This should enhance precision in distinguishing adjacent structures and yield consistent, reliable contouring results, ensuring patients receive the highest quality care possible.”

In 2022, RefleXion signed licensing agreement with Mirada Medical to advance personalised cancer treatment.